On October 16, 2023 OncoSpherix, Inc, reported that its CEO Dr. Margaret K. Offermann, MD, PhD, is delivering a keynote address at Biopharma Drug Discovery Nexus East Coast 2023 in Philadelphia on Wednesday, October 18 at 9:45 AM (Press release, OncoSpherix, OCT 16, 2023, https://oncospherix.com/oncospherix-presents-at-biopharma-drug-discovery-nexus-east-coast-2023-in-philadelphia-on-wednesday-october-18-at-945-am/ [SID1234636010]). Her presentation is entitled "Critical Decisions for Advancing Small Molecule Hypoxia-Inducible Factor Inhibitors for Advanced Cancer". She will share evidence using preclinical models that OncoSpehrix’s HIF inhibitors are effective at inhibiting primary tumor growth and metastases in many forms of cancer and show synergy when given in combination with several classes of systemic cancer treatment.